(Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -106.36%-4.85M | -156.82%-2.89M | -436.62%-7.37M | 258.81%9.9M | 37.21%-3.07M | -99.31%-2.35M | -112.55%-1.13M | -75.59%2.19M | 4,975.57%2.76M | -949.71%-4.9M |
Net income from continuing operations | 329.95%2.77M | -39.39%4.81M | -142.64%-1.8M | 2,390.04%7.88M | 97.03%-65.82K | -119.16%-1.2M | -48.95%7.94M | 132.14%4.22M | -108.92%-344.09K | -159.04%-2.22M |
Operating gains losses | -138.41%-524.13K | 94.40%-518.83K | 69.71%-292.68K | 70.69%-457.83K | 125.57%451.52K | 95.58%-219.85K | 5.36%-9.27M | -566.91%-966.36K | -177.72%-1.56M | 49.22%-1.77M |
Depreciation and amortization | 116.82%19.7K | -23.77%79.02K | -37.41%51.77K | -76.81%-34.07K | 157.85%52.24K | -54.50%9.08K | 43.76%103.66K | 225.79%82.71K | -222.82%-19.27K | 31.93%20.26K |
Asset impairment expenditure | ---- | ---- | ---- | ---- | ---- | ---- | -137.81%-127.54K | ---- | ---- | ---- |
Remuneration paid in stock | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Unrealized gains and losses of investment securities | -174.71%-2.34M | -337.10%-4.08M | 89.95%-414.57K | -365.55%-7.45M | -86.04%659.82K | 172.08%3.13M | 88.19%-933.3K | -36.66%-4.13M | 179.16%2.81M | 659.04%4.73M |
Deferred tax | 108.14%213.83K | -207.94%-2.12M | -224.51%-1.02M | 277.89%1.53M | 99.98%-147 | -196.08%-2.63M | 269.26%1.96M | 46.87%819.96K | -18,295.89%-859.27K | -9,760.16%-731.03K |
Change In working capital | -246.69%-4.99M | -33.19%-1.07M | -270.20%-3.89M | 208.23%8.44M | 15.33%-4.17M | -60.12%-1.44M | -107.62%-801.84K | -75.61%2.29M | 1,414.04%2.74M | -534.28%-4.93M |
-Change in receivables | 45.98%-309.37K | -172.13%-369.09K | 51.26%-232.09K | -42.61%171.1K | -70.34%264.59K | -183.21%-572.69K | -50.58%511.68K | -125.10%-476.21K | 376.41%298.16K | -34.17%891.95K |
-Change in payables and accrued expense | -102.02%-22.45K | 176.92%1.19M | 517.54%1.29M | 28.12%489.88K | -5,350.48%-1.71M | 670.08%1.11M | 22.08%429.4K | -39.56%209.69K | 256.70%382.36K | 133.13%32.54K |
-Change in other current assets | 67.58%-17.17K | -187.97%-31.3K | 133.61%83.12K | -48.06%696.54K | 43.96%-757.99K | -552.28%-52.98K | 195.98%35.58K | -48.47%35.58K | 5.57%1.34M | -11.72%-1.35M |
-Change in other working capital | -140.92%-4.64M | -4.39%-1.86M | -300.10%-5.04M | 889.31%7.08M | 56.21%-1.97M | -275.34%-1.93M | -119.39%-1.78M | --2.52M | --715.53K | ---4.5M |
Cash from discontinued investing activities | 0 | -1.39M | -17.35K | -22.23K | ||||||
Operating cash flow | -104.43%-4.85M | -280.07%-4.28M | -455.78%-7.39M | 196.94%8.53M | 37.66%-3.05M | -101.19%-2.37M | -112.55%-1.13M | -76.85%2.08M | 5,175.22%2.87M | -949.71%-4.9M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -60.00%2.45M | 57.32%2.08M | 91.39%-173.45K | -674.74%-6.48M | 522.03%2.61M | 62.99%6.11M | 122.91%1.32M | 39.52%-2.01M | 61.69%-835.8K | 116.02%420.1K |
Net PPE purchase and sale | --0 | --0 | --0 | --0 | --0 | --0 | 24.42%-711.81K | 7.41%-111.34K | 47.47%-431.57K | ---1.19K |
Net investment property transactions | --0 | ---- | ---- | ---- | --56.24K | --0 | -56.73%919.62K | ---- | ---- | --0 |
Net investment purchase and sale | -62.90%2.32M | 86.68%2.08M | 93.86%-173.45K | -22,809.60%-6.42M | 475.03%2.42M | 76.37%6.25M | 116.02%1.11M | 28.83%-2.82M | 98.82%-28.02K | 116.06%421.29K |
Net other investing changes | 195.20%127.88K | ---- | ---- | ---- | ---- | ---134.33K | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | 10.6M | 5.21M | ||||||||
Investing cash flow | -60.00%2.45M | 859.46%12.68M | 271.81%5.04M | -1,400.91%-1.09M | 522.03%2.61M | 62.99%6.11M | 122.91%1.32M | 11.91%-2.93M | 103.84%83.82K | 116.02%420.1K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -383.87%-1.19M | -78.13%-814.05K | 55.63%-185.67K | -2,305.77%-166.72K | -583.93%-215.96K | -245.69K | 78.66%-456.99K | 88.85%-418.49K | -100.26%-6.93K | 94.75%-31.58K |
Net issuance payments of debt | ---20K | ---40K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Net common stock issuance | -375.73%-1.17M | -69.38%-774.05K | 65.19%-145.67K | -2,305.77%-166.72K | -583.93%-215.96K | ---245.69K | 78.85%-456.99K | -41.00%-418.49K | 99.15%-6.93K | 94.75%-31.58K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -383.87%-1.19M | -78.13%-814.05K | 55.63%-185.67K | -2,305.77%-166.72K | -583.93%-215.96K | ---245.69K | 78.66%-456.99K | 88.85%-418.49K | -100.26%-6.93K | 94.75%-31.58K |
Net cash flow | ||||||||||
Beginning cash position | 374.60%9.74M | -14.40%2.05M | 278.92%12.63M | 1,125.09%4.86M | 12.24%5.51M | -14.40%2.05M | 75.97%2.4M | 298.84%3.33M | -14.80%396.45K | 64.36%4.91M |
Current changes in cash | -202.80%-3.59M | 2,988.46%7.58M | -98.32%-2.53M | 146.57%7.27M | 85.47%-654.79K | 35.92%3.5M | -124.48%-262.46K | -167.68%-1.28M | 639.84%2.95M | -70.20%-4.51M |
Effect of exchange rate changes | -47.80%-51.35K | 224.51%102.85K | -8,079.55%-359.25K | 3,808.10%497.48K | 91.75%-639 | 39.11%-34.74K | -118.84%-82.6K | 98.65%-4.39K | 52.94%-13.42K | -106.18%-7.74K |
End cash Position | 10.48%6.09M | 374.60%9.74M | 374.60%9.74M | 278.92%12.63M | 1,125.09%4.86M | 12.24%5.51M | -14.40%2.05M | -14.40%2.05M | 298.84%3.33M | -14.80%396.45K |
Free cash from | -104.43%-4.85M | -132.93%-4.28M | -475.94%-7.39M | 249.45%8.53M | 37.67%-3.05M | -76.14%-2.37M | -122.87%-1.84M | -78.56%1.96M | 304.64%2.44M | -949.92%-4.9M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.